Treatment
Corneal Cross-Linking
Corneal cross-linking (CXL) strengthens the cornea to halt the progression of keratoconus and post-refractive ectasia using riboflavin and UV light.
Guide price
From £2,399
surgeon's fee per eye (additional fees apply)
The £2,399 fee includes:
- Surgeon's fee for CXL procedure
- Riboflavin and UV treatment
- Post-operative follow-up appointments
Overview
Understanding the Procedure
Corneal cross-linking (CXL) is a minimally invasive procedure that strengthens the collagen bonds within the cornea. It is the gold-standard treatment for halting the progression of keratoconus — a condition where the cornea thins and bulges into a cone shape, causing distorted vision.
During the procedure, riboflavin (vitamin B2) drops are applied to the cornea, followed by controlled ultraviolet-A (UVA) light exposure. This combination creates new cross-links between collagen fibres, stiffening and stabilising the cornea.
Cross-linking does not reverse existing keratoconus but prevents further deterioration, preserving the patient's current level of vision and potentially avoiding the need for a corneal transplant in the future.
Miss Tina Khanam is a corneal specialist with extensive experience in managing keratoconus. She performs both epithelium-off (standard) and epithelium-on (transepithelial) cross-linking techniques depending on the individual case.
Speak with Miss Khanam
Leave your details to talk about Corneal Cross-Linking with Miss Khanam. She will arrange a time that suits you.
On Video
Watch Miss Khanam explain
Cone-shaped vision: decoding keratoconus and modern fixes for better sight
What is keratoconus? Join Miss Tina Khanam, a dedicated ophthalmologist, as she delves into this eye condition affecting the cornea. Keratoconus transforms the normally spherical cornea into a cone shape, leading to blurred vision and increased sensitivity.…
Benefits
What This Means for You
- Halts keratoconus progression in over 95% of cases
- May prevent the need for corneal transplant
- Minimally invasive day-case procedure
- Can be combined with other treatments (e.g. intrastromal ring segments)
- Proven long-term stability — effects last 10+ years
Our Approach
Consultant-Led Care
Miss Khanam conducts thorough corneal imaging including topography, tomography, and pachymetry to assess the stage and progression of keratoconus before recommending cross-linking.
Treatment is typically recommended for progressive keratoconus — where serial scans show the cornea is continuing to thin or steepen. Early intervention produces the best long-term outcomes.
Suitability
Is This Right for You?
- Patients with progressive keratoconus
- Post-refractive surgery ectasia
- Young adults where keratoconus is more likely to progress
- Patients with corneal thickness of at least 400 microns
Your Journey
From Consultation to Recovery
- Days 1-3. Moderate discomfort; bandage contact lens in place; vision blurry
- Days 4-7. Bandage lens removed; discomfort settling; vision still hazy
- Weeks 2-4. Vision gradually improving; mild corneal haze may be present
- Months 1-6. Corneal haze clearing; vision stabilising; corneal strengthening complete
Risks
Risks to Be Aware Of
- Corneal haze. Usually temporary and resolves within 3-6 months
- Discomfort for 2-3 days post-procedure. Pain relief and bandage contact lens provided
- Temporary vision reduction. Vision typically returns to baseline within 1-3 months
- Infection. Antibiotic drops and close monitoring
- Treatment failure (continued progression). Repeat cross-linking may be considered
Patient Reviews
What Patients Say
“My surgeon and her team is well organised. My surgeon gave information timely and easily accessible. Thank you.”
“My surgeon instructed and gave information in manageable chunks. I am very happy with the service. Thank you.”
“My surgeon was very helpful. I was very scared and my surgeon calmed me down and made me laugh. It was amazing.”
Common Questions
Frequently Asked Questions
Cross-linking is primarily designed to stabilise the cornea and prevent further deterioration. Some patients do experience a modest improvement in vision as the cornea stiffens, but this is not the primary goal.
Ready to talk it through?
Leave your details and Miss Khanam will arrange a time to talk about your options.
Related
Understanding Your Condition
Learn more about the conditions this treatment addresses. Knowledge is the first step toward confident decision-making.
Take the Next Step
Book a consultation to discuss Corneal Cross-Linking with your consultant. Transparent advice, no pressure, and a personalised plan for your vision.

